NCT07332104

Brief Summary

After obtaining informed consent from the patients, all the medical history and treatment records of the patients who underwent gastroscopy since the onset of the disease, as well as gastric fluid samples, including laboratory and imaging data, were collected and recorded. The medical history and treatment records and gastric fluid samples were analyzed.

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for all trials

Timeline
8mo left

Started Dec 2025

Shorter than P25 for all trials

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress34%
Dec 2025Dec 2026

First Submitted

Initial submission to the registry

December 14, 2025

Completed
1 day until next milestone

Study Start

First participant enrolled

December 15, 2025

Completed
28 days until next milestone

First Posted

Study publicly available on registry

January 12, 2026

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 15, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 15, 2026

Last Updated

January 12, 2026

Status Verified

December 1, 2025

Enrollment Period

1 year

First QC Date

December 14, 2025

Last Update Submit

December 28, 2025

Conditions

Keywords

Gastric cancerExtracellular vesicles

Outcome Measures

Primary Outcomes (1)

  • Surface plasmon resonance(SPR) detection of extracellular vesicles in gastric juice of patients with gastric cancer has large shift and spectral changes

    baseline

Study Arms (1)

gastric cancer

Patients diagnosed with gastric cancer

Diagnostic Test: In vitro surface plasmon resonance detection

Interventions

Gastric juice from patients was removed for isolation of extracellular vesicles and surface plasmon resonance detection in vitro

gastric cancer

Eligibility Criteria

Age40 Years - 70 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Gastric cancer and non-cancer patients

You may qualify if:

  • Patients underwent gastroscopy and treatment at the Endoscopy Center of Beijing Friendship Hospital, Capital Medical University, and received pathological biopsy.
  • Previous gastroscopy suggested the possibility of lesions.
  • No previous history of gastrointestinal cancer.

You may not qualify if:

  • Patients could not cooperate with the examination or had contraindications to endoscopy.
  • Previous history of gastrointestinal tumors, gastrointestinal surgery, physical and chemical injuries of the gastrointestinal tract.
  • Severe bile reflux.
  • Take simethicone and other defoaming agents before examination.
  • Patients with serious diseases of heart, lung, kidney, brain, blood and other important organs.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Biospecimen

Retention: SAMPLES WITHOUT DNA

Extracellular vesicles

MeSH Terms

Conditions

Stomach NeoplasmsDisease

Condition Hierarchy (Ancestors)

Gastrointestinal NeoplasmsDigestive System NeoplasmsNeoplasms by SiteNeoplasmsDigestive System DiseasesGastrointestinal DiseasesStomach DiseasesPathologic ProcessesPathological Conditions, Signs and Symptoms

Central Study Contacts

Hao-Su Zhan, Dr.

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

December 14, 2025

First Posted

January 12, 2026

Study Start

December 15, 2025

Primary Completion (Estimated)

December 15, 2026

Study Completion (Estimated)

December 15, 2026

Last Updated

January 12, 2026

Record last verified: 2025-12